Skip to main content
An official website of the United States government

Effects of Exercise and Nutrition Interventions During Platinum Chemotherapy on Neuropathy in Patients with Gastrointestinal Cancer

Trial Status: active

This phase II trial studies how well the effects of exercise and nutrition interventions work on the side effects of chemotherapy in patients with gastrointestinal cancer. Patients with gastrointestinal cancer often experience troublesome symptoms and side effects related to the cancer and treatment for their cancer. Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and severe side-effect of platinum-based chemotherapy. Not only does CIPN increase mortality by limiting the dose of chemotherapy, CIPN affects walking, writing, eating, and dressing via numbness, tingling, pain, cold sensitivity, and cramping in the hands and feet. Unfortunately there are very limited treatments for CIPN. This study may help researchers determine the impact of an exercise and nutritional intervention on CIPN in patients with gastrointestinal cancer.